These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31045658)

  • 1. Novel therapeutic strategies for renovascular disease.
    Eirin A; Textor SC; Lerman LO
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):383-389. PubMed ID: 31045658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney Intrinsic Mechanisms as Novel Targets in Renovascular Hypertension.
    Eirin A; Chade AR; Lerman LO
    Hypertension; 2024 Feb; 81(2):206-217. PubMed ID: 37869904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endovascular management of atherosclerotic renovascular disease: early results following primary intervention.
    Corriere MA; Pearce JD; Edwards MS; Stafford JM; Hansen KJ
    J Vasc Surg; 2008 Sep; 48(3):580-7; discussion 587-8. PubMed ID: 18727962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergent players in renovascular disease.
    Barsom SH; Glasstetter LM; Siddiqi S; Rajagopalan KS; Eirin A; Lerman LO
    Clin Sci (Lond); 2022 Feb; 136(3):239-256. PubMed ID: 35129198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherosclerotic process, renovascular disease and outcomes from bench to bedside.
    Lerman LO; Chade AR
    Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):583-7. PubMed ID: 17053471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renovascular Hypertension.
    Herrmann SM; Textor SC
    Endocrinol Metab Clin North Am; 2019 Dec; 48(4):765-778. PubMed ID: 31655775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic blockade of endothelin A and B receptors using macitentan in experimental renovascular disease.
    Tullos NA; Stewart NJ; Davidovich R; Chade AR
    Nephrol Dial Transplant; 2015 Apr; 30(4):584-93. PubMed ID: 25438341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renovascular disease in older adults.
    Herrera AH; Davidson RA
    Clin Geriatr Med; 1998 May; 14(2):237-54. PubMed ID: 9536103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerotic renal artery stenosis and revascularization.
    Choi SS
    Expert Rev Cardiovasc Ther; 2014 Dec; 12(12):1419-25. PubMed ID: 25370342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues in renovascular disease and ischemic nephropathy: beyond ASTRAL.
    Textor SC
    Curr Opin Nephrol Hypertens; 2011 Mar; 20(2):139-45. PubMed ID: 21157335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous Mesenchymal Stem Cells Increase Cortical Perfusion in Renovascular Disease.
    Saad A; Dietz AB; Herrmann SMS; Hickson LJ; Glockner JF; McKusick MA; Misra S; Bjarnason H; Armstrong AS; Gastineau DA; Lerman LO; Textor SC
    J Am Soc Nephrol; 2017 Sep; 28(9):2777-2785. PubMed ID: 28461553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of atherosclerotic renovascular disease.
    Adamczak M; Więcek A
    Kidney Blood Press Res; 2011; 34(4):277-83. PubMed ID: 21691131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant intervention blunts renal injury in experimental renovascular disease.
    Chade AR; Rodriguez-Porcel M; Herrmann J; Zhu X; Grande JP; Napoli C; Lerman A; Lerman LO
    J Am Soc Nephrol; 2004 Apr; 15(4):958-66. PubMed ID: 15034098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerotic renovascular disease and renal impairment: can we predict the effect of intervention?
    Mui KW; Woittiez AJ; Navis G
    Curr Hypertens Rep; 2007 Apr; 9(2):140-7. PubMed ID: 17442226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary management of atherosclerotic renovascular disease.
    Edwards MS; Corriere MA
    J Vasc Surg; 2009 Nov; 50(5):1197-210. PubMed ID: 19595533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and renovascular disease.
    Zhang X; Lerman LO
    Am J Physiol Renal Physiol; 2015 Aug; 309(4):F273-9. PubMed ID: 26041447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and management of renovascular hypertension and ischemic nephropathy.
    Yerram P; Karuparthi PR; Chaudhary K
    Minerva Urol Nefrol; 2012 Mar; 64(1):63-72. PubMed ID: 22402318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revascularization in renal artery stenosis.
    Foy A; Ruggiero NJ; Filippone EJ
    Cardiol Rev; 2012; 20(4):189-93. PubMed ID: 22314144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renovascular hypertension: is there still a role for stent revascularization?
    Textor SC
    Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):525-30. PubMed ID: 23917028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease.
    Kelsen S; Hall JE; Chade AR
    Am J Physiol Renal Physiol; 2011 Jul; 301(1):F218-25. PubMed ID: 21478482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.